Amgen, Horizon Say FTC Constitutionality Key To Merger Row
By Bryan Koenig · August 11, 2023, 8:01 PM EDT
Amgen and Horizon Therapeutics urged an Illinois federal judge Thursday to preserve their attacks on the constitutionality of the Federal Trade Commission and its in-house process as part of the agency...
To view the full article, register now.
Try a seven day FREE Trial
Already a subscriber? Click here to login